Manufacturer record
Ultra Drugs Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
16 batches manufactured by Ultra Drugs Pvt. Ltd (Himachal Pradesh) were declared Not of Standard Quality between August 2021 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: UGT-25627L, Levocetirizine Hydrochloride & Montelukast Sodium tablets IP (exp Apr 2027). DTL, Bengaluru, Karnataka (state lab) found it not of standard quality: Description. Listed in the September 2026 alert.
Records by type
16 records linked to Ultra Drugs Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Levocetirizine Hydrochloride & Montelukast Sodium tablets IP | Batch UGT-25627LMfg May 2025 · Exp Apr 2027 | DescriptionDescription | DTL, Bengaluru, KarnatakaState lab | Sep 2026 |
| Cefpodoxime Proxetil Dispersible Tablets | Batch UCT-26285AMfg Jul 2026 · Exp Jun 2028 | DescriptionDescription | SDTL, PunjabState lab | Sep 2026 |
| Amikacin Sulphate Injection IP | Batch UGL-24375AMfg Oct 2024 · Exp Sep 2026 | The sample does not conform to I.P. with respect to test for ' Particulate Matter' and is also not of standard quality for the reason stated under DescriptionDescription | CDL, KolkataCDSCO lab | Aug 2026 |
| Levocetirizine Hydrochloride and Montelukast Sodium Tablets IP | Batch UGT-25293LMfg Mar 2025 · Exp Feb 2027 | The sample does not conform to I.P.w.r.t. the test for DissolutionDissolution | SDTL, AssamState lab | Feb 2026 |
| Levocetirizine Hydrochloride & Montelukast Sodium Tablets IP (Alticet-M) | Batch UGT-24842BMfg Aug 2024 · Exp Jul 2026 | Failed Description (Spots)Description | DTL, PuducherryState lab | Dec 2025 |
| Baptar NM Tablet (Pregabalin Methylcobalamin & Nortriptyline Tablets) | Batch UGT-25134EMfg Jan 2025 · Exp Dec 2026 | AssayAssay | DTL Baddi H.PState lab | Oct 2025 |
| CEFPODOXIME PROXETIL DISPERSIBLE Tablets | Batch UCT-25327HMfg Aug 2025 · Exp Jul 2027 | Uniformity of Dispersion.Uniformity of weight/content | SDTL, PunjabState lab | Sep 2025 |
| Amoxycillin & Potassium Clavulanate for Oral Suspension, | Batch UPS-245CMfg Jan 2024 · Exp Jun 2025 | The drug product Amoxcycillin and potassium Clavulanate for Oral suspension is official in the current edition of IP 2022. But the designation in conjiction with the product title Amoxycillin and Potassium Clavulanate for Oral suspension IP is not mentioned on the product LabelLabelling | State Lab, Drugs Control Laboratory, TelanganaState lab | May 2025 |
| Methylcobalamin, Thiamine HCl, Pyridoxine HCl, D- Panthenol and Nicotinamide Injection (Nuropat) | Batch UGA-24436EMfg Aug 2024 · Exp Jan 2026 | Particulate Matter and Assay of MethylcobalaminAssay | CDL, KolkataCDSCO lab | Mar 2025 |
| Pantoprazole Gastro-resistant and Domperidone Prolonged- release Capsules IP (Unipraz - DSR) | Batch UC-23001CMfg Jul 2023 · Exp Jun 2025 | "Dissolution of Domperidone"Dissolution | CDTL MumbaiCDSCO lab | Dec 2024 |
| Rabeprazole Sodium (Enteric Coated) And Domperidone (Sustained Release) Capsules (ZABIL- DSR) | Batch UD2C- 23469EMfg Jun 2023 · Exp May 2025 | Dissolution of Rabeprazole & Domperidone, Assay of DomperidoneAssay | CDL KolkataCDSCO lab | Oct 2024 |
| Itraconazole Capsules BP 100 mg | Batch UC-23240AMfg Oct 2023 · Exp Sep 2025 | DissolutionDissolution | CDL KolkataCDSCO lab | Jul 2024 |
| SOFTOM-D Omeprazole and Domperidone Capsules IP | Batch UD2C- 23252BMfg Apr 2023 · Exp Mar 2025 | THE SAMPLE DOES NOT COMPLY WITH IP REQUIREMENTS FOR OMEPRAZOLE AND DOMPERIDONE CAPSULES FOR THE DISSOLUTION TEST (OMEPRAZOLE).Dissolution | State Lab MaharashtraState lab | Jun 2024 |
| Cefpodoxime Proxetil for Oral Suspension IP | Batch UCST- 2310Mfg Mar 2023 · Exp Feb 2025 | pHpH | RDTL ChandigarhCDSCO lab | Aug 2023 |
| Cefpodoxime Proxetil Dispersible Tablets 200 mg | Batch UCT-22159Mfg May 2022 · Exp Apr 2024 | Uniformity of DispersionUniformity of weight/content | CDL KolkataCDSCO lab | Nov 2022 |
| Doulcet-M Tablets, (Levocetrizine Dihydrochloride & Montelukast Sodium) | Batch UDT-20163CMfg Feb 2020 · Exp Jan 2022 | Dissolution of MontelukastDissolution | RDTL GuwahatiState lab | Aug 2021 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.